Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

325 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
SEAD reference panel with 22,134 haplotypes boosts rare variant imputation and genome-wide association analysis in Asian populations.
Yang MY, Zhong JD, Li X, Tian G, Bai WY, Fang YH, Qiu MC, Yuan CD, Yu CF, Li N, Yang JJ, Liu YH, Yu SH, Zhao WW, Liu JQ, Sun Y, Cong PK, Khederzadeh S, Zhao PP, Qian Y, Guan PL, Gu JX, Gai SR, Yi XJ, Tao JG, Chen X, Miao MM, Lei LX, Xu L, Xie SY, Li JC, Guo JF, Karasik D, Yang L, Tang BS, Huang F, Zheng HF. Yang MY, et al. Among authors: xie sy. Nat Commun. 2024 Dec 30;15(1):10839. doi: 10.1038/s41467-024-55147-4. Nat Commun. 2024. PMID: 39738056 Free PMC article.
Impeding Nucleotide-Binding Oligomerization Domain-Like Receptor 3 Inflammasome Ameliorates Cardiac Remodeling and Dysfunction in Obesity-Associated Cardiomyopathy.
Liu SQ, Xie SY, Zhang T, Zhang H, Chen MY, Xing Y, Zhao N, Li L, Chen S, Wang SS, Zeng XF, Deng W, Tang QZ. Liu SQ, et al. Among authors: xie sy. J Am Heart Assoc. 2024 Dec 3;13(23):e035234. doi: 10.1161/JAHA.124.035234. Epub 2024 Nov 27. J Am Heart Assoc. 2024. PMID: 39604027 Free PMC article.
Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a randomised, single-centre, double-blind, placebo-controlled, phase 2 trial.
Liu SL, Li XY, Yang JH, Wen DX, Guo SS, Liu LT, Li YF, Luo MJ, Xie SY, Liang YJ, Sun XS, Yang ZC, Lv XF, Luo DH, Li JB, Liu Q, Wang P, Guo L, Mo HY, Sun R, Yang Q, Lan KQ, Jia GD, Li R, Zhao C, Xu RH, Chen QY, Tang LQ, Mai HQ. Liu SL, et al. Among authors: xie sy. Lancet Oncol. 2024 Dec;25(12):1563-1575. doi: 10.1016/S1470-2045(24)00504-7. Epub 2024 Nov 7. Lancet Oncol. 2024. PMID: 39522541 Clinical Trial.
325 results